Cargando…

Cu–Ferrocene‐Functionalized CaO(2) Nanoparticles to Enable Tumor‐Specific Synergistic Therapy with GSH Depletion and Calcium Overload

The conversion of endogenous H(2)O(2) into toxic hydroxyl radical ((•)OH) via catalytic nanoparticles is explored for tumor therapy and received considerable success. The intrinsic characteristics of microenvironment in tumor cells, such as limited H(2)O(2) and overexpressed glutathione (GSH), hinde...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Hanjing, Chu, Qiang, Fang, Chao, Cao, Guodong, Han, Gaorong, Li, Xiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292872/
https://www.ncbi.nlm.nih.gov/pubmed/34032026
http://dx.doi.org/10.1002/advs.202100241
_version_ 1783724910645870592
author Kong, Hanjing
Chu, Qiang
Fang, Chao
Cao, Guodong
Han, Gaorong
Li, Xiang
author_facet Kong, Hanjing
Chu, Qiang
Fang, Chao
Cao, Guodong
Han, Gaorong
Li, Xiang
author_sort Kong, Hanjing
collection PubMed
description The conversion of endogenous H(2)O(2) into toxic hydroxyl radical ((•)OH) via catalytic nanoparticles is explored for tumor therapy and received considerable success. The intrinsic characteristics of microenvironment in tumor cells, such as limited H(2)O(2) and overexpressed glutathione (GSH), hinder the intracellular (•)OH accumulation and thus weaken therapeutic efficacy considerably. In this study, fine CaO(2) nanoparticles with Cu–ferrocene molecules at the surface (CaO(2)/Cu–ferrocene) are successfully designed and synthesized. Under an acidic condition, the particles release Ca(2+) ions and H(2)O(2) in a rapid fashion, while they can remain stable in neutral. In addition, agitated production of (•)OH occurs following the Fenton reaction of H(2)O(2) and ferrocene molecules, and GSH is consumed by Cu(2+) ions to avoid the potential (•)OH consumption. More interestingly, in addition to the exogenous Ca(2+) released by the particles, the enhanced (•)OH production facilitates intracellular calcium accumulation by regulating Ca(2+) channels and pumps of tumor cells. It turns out that promoted (•)OH induction and intracellular calcium overload enable significant in vitro and in vivo antitumor phenomena.
format Online
Article
Text
id pubmed-8292872
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-82928722021-07-22 Cu–Ferrocene‐Functionalized CaO(2) Nanoparticles to Enable Tumor‐Specific Synergistic Therapy with GSH Depletion and Calcium Overload Kong, Hanjing Chu, Qiang Fang, Chao Cao, Guodong Han, Gaorong Li, Xiang Adv Sci (Weinh) Research Articles The conversion of endogenous H(2)O(2) into toxic hydroxyl radical ((•)OH) via catalytic nanoparticles is explored for tumor therapy and received considerable success. The intrinsic characteristics of microenvironment in tumor cells, such as limited H(2)O(2) and overexpressed glutathione (GSH), hinder the intracellular (•)OH accumulation and thus weaken therapeutic efficacy considerably. In this study, fine CaO(2) nanoparticles with Cu–ferrocene molecules at the surface (CaO(2)/Cu–ferrocene) are successfully designed and synthesized. Under an acidic condition, the particles release Ca(2+) ions and H(2)O(2) in a rapid fashion, while they can remain stable in neutral. In addition, agitated production of (•)OH occurs following the Fenton reaction of H(2)O(2) and ferrocene molecules, and GSH is consumed by Cu(2+) ions to avoid the potential (•)OH consumption. More interestingly, in addition to the exogenous Ca(2+) released by the particles, the enhanced (•)OH production facilitates intracellular calcium accumulation by regulating Ca(2+) channels and pumps of tumor cells. It turns out that promoted (•)OH induction and intracellular calcium overload enable significant in vitro and in vivo antitumor phenomena. John Wiley and Sons Inc. 2021-05-24 /pmc/articles/PMC8292872/ /pubmed/34032026 http://dx.doi.org/10.1002/advs.202100241 Text en © 2021 The Authors. Advanced Science published by Wiley‐VCH GmbH https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Kong, Hanjing
Chu, Qiang
Fang, Chao
Cao, Guodong
Han, Gaorong
Li, Xiang
Cu–Ferrocene‐Functionalized CaO(2) Nanoparticles to Enable Tumor‐Specific Synergistic Therapy with GSH Depletion and Calcium Overload
title Cu–Ferrocene‐Functionalized CaO(2) Nanoparticles to Enable Tumor‐Specific Synergistic Therapy with GSH Depletion and Calcium Overload
title_full Cu–Ferrocene‐Functionalized CaO(2) Nanoparticles to Enable Tumor‐Specific Synergistic Therapy with GSH Depletion and Calcium Overload
title_fullStr Cu–Ferrocene‐Functionalized CaO(2) Nanoparticles to Enable Tumor‐Specific Synergistic Therapy with GSH Depletion and Calcium Overload
title_full_unstemmed Cu–Ferrocene‐Functionalized CaO(2) Nanoparticles to Enable Tumor‐Specific Synergistic Therapy with GSH Depletion and Calcium Overload
title_short Cu–Ferrocene‐Functionalized CaO(2) Nanoparticles to Enable Tumor‐Specific Synergistic Therapy with GSH Depletion and Calcium Overload
title_sort cu–ferrocene‐functionalized cao(2) nanoparticles to enable tumor‐specific synergistic therapy with gsh depletion and calcium overload
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292872/
https://www.ncbi.nlm.nih.gov/pubmed/34032026
http://dx.doi.org/10.1002/advs.202100241
work_keys_str_mv AT konghanjing cuferrocenefunctionalizedcao2nanoparticlestoenabletumorspecificsynergistictherapywithgshdepletionandcalciumoverload
AT chuqiang cuferrocenefunctionalizedcao2nanoparticlestoenabletumorspecificsynergistictherapywithgshdepletionandcalciumoverload
AT fangchao cuferrocenefunctionalizedcao2nanoparticlestoenabletumorspecificsynergistictherapywithgshdepletionandcalciumoverload
AT caoguodong cuferrocenefunctionalizedcao2nanoparticlestoenabletumorspecificsynergistictherapywithgshdepletionandcalciumoverload
AT hangaorong cuferrocenefunctionalizedcao2nanoparticlestoenabletumorspecificsynergistictherapywithgshdepletionandcalciumoverload
AT lixiang cuferrocenefunctionalizedcao2nanoparticlestoenabletumorspecificsynergistictherapywithgshdepletionandcalciumoverload